Buffering action of endogenous nitric oxide on the adrenocortical secretagogue effect of endothelins is the rat

Citation
G. Mazzocchi et al., Buffering action of endogenous nitric oxide on the adrenocortical secretagogue effect of endothelins is the rat, INT J MOL M, 7(1), 2001, pp. 55-59
Citations number
17
Categorie Soggetti
Medical Research General Topics
Journal title
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
ISSN journal
11073756 → ACNP
Volume
7
Issue
1
Year of publication
2001
Pages
55 - 59
Database
ISI
SICI code
1107-3756(200101)7:1<55:BAOENO>2.0.ZU;2-4
Abstract
The secretagogue effect of endothelins (ETs) on the rat adrenal cortex is m ediated by the ETB receptor. ETB receptors are coupled with nitric oxide (N O) synthase (NOS), and NO is known to inhibit steroid-hormone secretion fro m adrenal cortex. We investigated whether ETB-mediated NO production interf eres with the stimulatory action of ETs on rat adrenal cortex. The selectiv e agonist of ETB receptor BQ-3020 concentration-dependentIy increased aldos terone secretion from dispersed zona glomerulosa (ZG) cells and corticoster one secretion from dispersed zona fasciculata-reticularis (ZF/R) cells, and the NOS inhibitor NG-nitro-L-arginine methylester (L-NAME) potentiated the effect of BQ-3020 in a concentration-dependent manner. The guanylate cycla se inhibitor Ly-83583, at a concentration suppressing guanylin-and L-argini ne-induced cyclic-GMP release from dispersed adrenocortical cells, did not affect the secretory response of ZG and ZF/R cells to BQ-3020. ET-I, an ago nist of both ETA and ETB receptors, stimulated the release of both aldoster one and corticosterone by in situ perfused rat adrenal gland. This effect w as potentiated by L-NAME and unaffected by Ly-83583. Collectively, our find ings allow us to suggest that endogenous NO exerts in vivo and in vitro a c yclic-GMP-independent buffering action on the ETB receptor-mediated adrenoc ortical secretagogue action of ETs.